TSC2 and lymphangioleiomyomatosis: Consistent with extensive previous data and Knudson’s two-hit hypothesis [38], we identified biallelic inactivation of TSC2 or TSC1 in 30 of 32 angiomyolipomas and LAM tumors including point mutations, small indels, large genomic deletions, and copy neutral LOH.